Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Neutra Corp.
- Market Cap
- Unavailable
- Price
- $0.0002
- % Change (Daily % change from the live per-ticker quote feed.)
- +33.33%
- Volume
- 1.5K
About
Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.
Quick stats
Shares outstanding—
Computed float2.9B
Float / sharesUnknown
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001512886
Websitehttps://neutrainc.com
AI Summary
AI-generated1/3
minorbullishoperations update
Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth
Neutra Corp announced a strategic refocusing of its corporate resources to drive the growth of its wholly owned subsidiary, Neutra Life Sciences, a clinical research Site Management Organization.
The company plans to accelerate outreach to clinical trial sponsors and CROs throughout the second half of 2026, targeting visibility at industry conferences including the SCRS Global Site Solutions Summit and Obesity Week 2026.
As part of this realignment, Neutra Corp entered into a Securities Purchase Agreement Reversal and Debt Settlement Agreement with VIVIS Corporation to align capital behind its core life sciences strategy.
Red flags
- Securities Purchase Agreement Reversal suggests the unwinding of a previous financing arrangement, which typically indicates a cleanup of complex or dilutive funding instruments.